Sipuleucel-T: An Autologous Cellular Immunotherapy for Patients with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Dr Andy Stubbs the Senior Medical Director at Dendreon joined us at the World Vaccine Congress Washington to talk to us about Sipuleucel-T, an autologous Cellular Immunotherapy for patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. Dr Stubbs guided us through the following: Introduction to prostate cancer Natural History of Prostate Cancer Overview of sipuleucel-T & Pre-clinical …